Latest
Thursday 19 November 2026
ABCMONEY
FTSE 10010,551.17down −1.30%
FTSE 25024,364.17down −0.12%
GBP/USD1.3134down −0.14%
GBP/EUR1.1974down −0.03%
Bank Rate4.00%up Up 0.25
Brent$89.30up +0.15%

Business

Companies, results, deals and the boardroom

2,914 stories · Updated

Business

Livsayis FDA Approval Hands Regeneron a New Neurology Franchise

The Livsayis FDA approval gives Regeneron its first siRNA drug and first neurology medicine, treating generalized myasthenia gravis with four doses a year. Keith Howard ·

Latest in Business

More stories